Imperial has acquired a 25% stake in Mauritius-based Vicore Health, enhancing its market access capabilities within the complex healthcare regulatory landscape in Africa.

Target Information

Imperial's Market Access Healthcare division has made a strategic investment in Vicore Health, a burgeoning provider of health product industry services and technology based in Mauritius. Vicore Health specializes in Pharmacovigilance, Governance, Regulatory, and Medical Affairs solutions, positioning itself as a critical partner for companies navigating the complex healthcare landscape in Africa. Imperial's investment yields a 25% stake in Vicore Health, effective from 1 October 2021.

The company serves a diverse clientele that includes pharmaceutical, medical device, and complementary medicine manufacturers, as well as marketing authorization holders operating throughout Africa and emerging markets. Vicore Health provides a variety of services tailored to customer needs, ranging from fully managed solutions with technological support to flexible workload management for in-house teams.

Industry Overview in Mauritius

The healthcare market in Mauritius, as in much of Africa, is characterized by a blend of opportunities and challenges. The region's health system has witnessed significant developments, influenced by government initiatives and international partnership